At a glance
ClinicalIndex Comparison RecordN/ACompleted· 1,365 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Evaluation of VIMA With Sevorane in Adult Patients Required General Anesthesia for Surgery in Terms of Quality of Anesthesia and Its Influence on Cardiovascular System in Common Clinical Practice (SEVOPROTECTION)
In Brief
An observational study for Anesthesia, General. Completed, enrolled 1,365 participants across 10 sites.
Detailed Summary
The main objective of this post-marketing observational study (PMOS) is to collect data of using general anesthesia in patients undergoing any surgery to create local recommendations. These data will be based on the evaluation of volatile induction and maintenance anesthesia (VIMA) with Sevorane® (sevoflurane) in adult patients requiring general anesthesia for surgery in terms of quality of anesthesia and its influence on the cardiovascular system in common clinical practice in Ukraine.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsAnesthesia, General
CountriesUkraine
Collaborators--
Timeline
N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedJan 2011
Enrollment StartApr 2011
Primary CompletionDec 2011
TodayJul 2026
First PostedJan 24, 2011
Enrollment StartApr 1, 2011
Primary CompletionDec 1, 2011
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 15.4 years ago